Simulations Plus Reports Mixed Q3 2026 Results Amid Altaris Acquisition

  • Total revenue increased 7% YoY to $21.9M in Q3 2026, with services revenue up 20% and software revenue flat.
  • Net income swung to a profit of $3.6M from a loss of $67.3M in the prior-year quarter.
  • Adjusted EBITDA margin held steady at 36% of total revenue.
  • Company agreed to be acquired by Altaris, LLC for an undisclosed sum, with expected closing in Q4 2026.

Simulations Plus's Q3 results highlight a strategic shift toward services-driven revenue amid broader industry trends in model-informed and AI-accelerated drug development. The Altaris acquisition positions the company for potential expansion, but integration risks loom as it navigates this transition.

Integration Challenges
How the pending Altaris acquisition will impact Simulations Plus's operational focus and strategic direction.
Revenue Diversification
Whether the company can sustain its services revenue growth while maintaining software stability.
Market Positioning
The pace at which Simulations Plus can expand its AI-accelerated drug development solutions under new ownership.